These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26603890)

  • 1. Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin.
    Wang W; Zhou QT; Sun SP; Denman JA; Gengenbach TR; Barraud N; Rice SA; Li J; Yang M; Chan HK
    AAPS J; 2016 Mar; 18(2):372-84. PubMed ID: 26603890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.
    Zhou QT; Sun SP; Chan JG; Wang P; Barraud N; Rice SA; Wang J; Li J; Chan HK
    Mol Pharm; 2015 Aug; 12(8):2594-603. PubMed ID: 25423590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.
    Mangal S; Huang J; Shetty N; Park H; Lin YW; Yu HH; Zemlyanov D; Velkov T; Li J; Zhou QT
    Int J Pharm; 2019 Apr; 561():102-113. PubMed ID: 30797863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.
    Zhou QT; Gengenbach T; Denman JA; Yu HH; Li J; Chan HK
    AAPS J; 2014 Jan; 16(1):37-47. PubMed ID: 24129586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.
    Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT
    Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Much Surface Coating of Hydrophobic Azithromycin Is Sufficient to Prevent Moisture-Induced Decrease in Aerosolisation of Hygroscopic Amorphous Colistin Powder?
    Zhou QT; Loh ZH; Yu J; Sun SP; Gengenbach T; Denman JA; Li J; Chan HK
    AAPS J; 2016 Sep; 18(5):1213-1224. PubMed ID: 27255350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK
    J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.
    Mangal S; Park H; Zeng L; Yu HH; Lin YW; Velkov T; Denman JA; Zemlyanov D; Li J; Zhou QT
    Int J Pharm; 2018 Sep; 548(1):443-453. PubMed ID: 30008433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Das SC
    Int J Pharm; 2018 May; 543(1-2):318-327. PubMed ID: 29626509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J; Kutter JP; Mu H; Moodley A; Yang M
    Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface Composition and Aerosolization Stability of an Inhalable Combinational Powder Formulation Spray Dried Using a Three-Fluid Nozzle.
    Shetty N; Zhang Y; Park H; Zemlyanov D; Shah D; He A; Ahn P; Mutukuri TT; Chan HK; Zhou QT
    Pharm Res; 2020 Oct; 37(11):219. PubMed ID: 33037471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.
    Wang J; Guo Y; Lu W; Liu X; Zhang J; Sun J; Chai G
    Int J Pharm; 2024 Jun; 658():124208. PubMed ID: 38723731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalable Nanocomposite Microparticles with Enhanced Dissolution and Superior Aerosol Performance.
    Zhu C; Chen J; Yu S; Que C; Taylor LS; Tan W; Wu C; Zhou QT
    Mol Pharm; 2020 Sep; 17(9):3270-3280. PubMed ID: 32643939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalable liposomal powder formulations for co-delivery of synergistic ciprofloxacin and colistin against multi-drug resistant gram-negative lung infections.
    Yu S; Wang S; Zou P; Chai G; Lin YW; Velkov T; Li J; Pan W; Zhou QT
    Int J Pharm; 2020 Feb; 575():118915. PubMed ID: 31816354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored Antibiotic Combination Powders for Inhaled Rotational Antibiotic Therapy.
    Lee SH; Teo J; Heng D; Ng WK; Zhao Y; Tan RB
    J Pharm Sci; 2016 Apr; 105(4):1501-12. PubMed ID: 27019964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V; Park H; Zemlyanov D; Bhujbal SV; Ahmed MU; Azad MAK; Li J; Zhou QT
    Pharm Res; 2022 Nov; 39(11):2781-2799. PubMed ID: 35915320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.